AGEN Competitors & Alternatives
Compare Agenus Inc. with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
AGEN
Main Stock$3.33
Tradestie Score
50
Market Cap
$124.27M
Revenue Growth
0.3%
Analyst Upside
+270.0%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$350.67
|
$160.70B | 24.5 | 58 | Compare |
|
GILD
Gilead Sciences Inc
|
$138.76
|
$137.92B | 19.8 | 56 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$715.68
|
$46.96B | 35.3 | 61 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$87.21
|
$24.57B | - | 48 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$179.04
|
$22.61B | 20.9 | 64 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$132.26
|
$13.59B | 27.5 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$42.80
|
$11.09B | 14.9 | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$48.83
|
$10.74B | - | 53 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.17
|
$10.04B | 19.2 | 54 | Compare |
|
TECH
Bio-Techne Corp.
|
$52.35
|
$9.33B | 96.1 | 55 | Compare |
More AGEN Analysis
Data updated: Mar 31, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry